Search
for
Did you mean Immune Checkpoint Inhibitors?
Sort by
Research 30 of 1000+
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- 44391 ICI Therapy Toxicities in Psoriasis
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Immune checkpoint inhibitor‐related alopecia: Insight into the pathophysiology utilizing non‐invasive diagnostic techniques
- Wnt is back in drugmakers' sights, but is it druggable?
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
- Cemiplimab-Induced Alopecia Areata
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- The role of lymphocytes in the development and treatment of alopecia areata
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Biological therapy in the treatment of melanoma
- 24 ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Cutaneous manifestations associated with immune checkpoint inhibitors
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions